<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">ISRN Endocrinol</journal-id><journal-id journal-id-type="iso-abbrev">ISRN Endocrinol</journal-id><journal-id journal-id-type="publisher-id">ISRN.ENDOCRINOLOGY</journal-id><journal-title-group><journal-title>ISRN Endocrinology</journal-title></journal-title-group><issn pub-type="ppub">2090-4630</issn><issn pub-type="epub">2090-4649</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24729886</article-id><article-id pub-id-type="pmc">3960729</article-id><article-id pub-id-type="doi">10.1155/2014/864897</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Study</subject></subj-group></article-categories><title-group><article-title>Effect of Aerobic Training on Glucose Control and Blood Pressure in T2DDM East African Males</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2340-9875</contrib-id><name><surname>Yan</surname><given-names>Huimin</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Prista</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ranadive</surname><given-names>Sushant M.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Damasceno</surname><given-names>Albertino</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Caupers</surname><given-names>Paula</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kanaley</surname><given-names>Jill A.</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fernhall</surname><given-names>Bo</given-names></name><xref ref-type="aff" rid="I5">
<sup>5</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Exercise and Cardiovascular Research Laboratory, Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Champaign, IL 61801, USA</aff><aff id="I2"><sup>2</sup>Faculty of Physical Education and Sports Sciences, Universidade Pedag&#x000f3;gica, 1100 Maputo, Mozambique</aff><aff id="I3"><sup>3</sup>Faculty of Medicine, Eduardo Mondlane University, 1100 Maputo, Mozambique</aff><aff id="I4"><sup>4</sup>Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO 65211, USA</aff><aff id="I5"><sup>5</sup>Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL 60612, USA</aff><author-notes><corresp id="cor1">*Huimin Yan: <email>yanne2004@gmail.com</email></corresp><fn fn-type="other"><p>Academic Editors: Z. Canturk, R. P. Hoffman, M. Karadeniz, and Y. Nishida</p></fn></author-notes><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>4</day><month>3</month><year>2014</year></pub-date><volume>2014</volume><elocation-id>864897</elocation-id><history><date date-type="received"><day>5</day><month>11</month><year>2013</year></date><date date-type="accepted"><day>20</day><month>1</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Huimin Yan et al.</copyright-statement><copyright-year>2014</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>
<italic>Background.</italic> Exercise training intervention is underused in the management of type 2 diabetes mellitus in East Africa. 
<italic>Methods.</italic> 41 physically-active males with type 2 diabetes mellitus living in Mozambique were recruited and randomly assigned to 12 weeks of supervised exercise of low intensity exercise (LEX), vigorous intensity exercise (VEX), or to a control group (CON). Since there were no differences for any outcome variables between the exercise groups, VEX and LEX were combined into one exercise group (EX). <italic>Results.</italic> Age and baseline body weight were similar between EX and CON. Plasma glucose at 120&#x02009;min following glucose load (Glu 120) was significantly reduced in the EX group after training (Glu 120&#x02009;:&#x02009;17.3&#x02009;mmol/L to 15.0&#x02009;mmol/L, <italic>P</italic> &#x0003c; 0.05), whereas Glu 120 remained unchanged in the CON (Glu 120&#x02009;:&#x02009;16.6&#x02009;mmol/L to 18.7&#x02009;mmol/L). After controlling for baseline blood pressure (BP), posttraining systolic BP and diastolic BP were lower in the EX group than in the CON group (EX: 129/77&#x02009;mm&#x02009;Hg, CON: 152/83&#x02009;mm&#x02009;Hg, <italic>P</italic> &#x0003c; 0.05). <italic>Conclusion.</italic> Adding exercise to already active African men with type 2 diabetes improved glucose control and BP levels without concomitant changes in weight.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Diabetes is an increasing cause of morbidity and mortality in Africa. According to the World Health Organization (WHO), in 2000, there were 133,000 known individuals with type 2 diabetes in Mozambique and possibly an equal number of undiagnosed cases. Globally there is a rapid increase in the incidence of diabetes but developing countries have contributed substantially to the increased incidence [<xref rid="B1" ref-type="bibr">1</xref>], mainly as a consequence of urbanization [<xref rid="B2" ref-type="bibr">2</xref>]. It is projected that, by 2030, the number of people with diabetes will more than double in Mozambique.</p><p>Urbanization is associated with altered diet and decreased physical activity [<xref rid="B2" ref-type="bibr">2</xref>]. Although physical activity levels are declining in developing countries, they are still considerably higher than developed countries, especially in rural areas [<xref rid="B3" ref-type="bibr">3</xref>]. In Mozambique, many individuals walk more than one hour per day, as walking is a primary mode of transportation.</p><p>Exercise is widely prescribed in developed countries as a lifestyle intervention to control glucose and blood pressure (BP) in type 2 diabetic patients [<xref rid="B4" ref-type="bibr">4</xref>&#x02013;<xref rid="B7" ref-type="bibr">7</xref>]. Because of their inherent daily physical activity in developing countries, exercise is seldom prescribed to patients with type 2 diabetes. Therefore, little is known if a structured exercise program added to an already active lifestyle would affect glucose control and BP in this population with type 2 diabetes. We hypothesized that a 12-week (wk) aerobic exercise program would improve glucose control and lower BP in already active type 2 diabetics living in Mozambique.</p></sec><sec id="sec2"><title>2. Methods</title><sec id="sec2.1"><title>2.1. Subjects</title><p>Forty-one male subjects, between the ages of 40 and 70, diagnosed with type 2 diabetes for a minimum of 12 months were recruited from a local diabetes clinic in Maputo, Mozambique, and 41 subjects completed the study. All subjects gave written consent. This study was approved by the local Institutional Review Board. All subjects walked a minimum of one hour per day as part of their daily lifestyle and were free from any known disease other than type 2 diabetes and hypertension, including diagnosed cardiovascular disease. <xref ref-type="table" rid="tab1"> Table 1</xref> summarizes the medications used by the exercise intervention (EX) and control group (CON).</p></sec><sec id="sec2.2"><title>2.2. Measurements</title><p>Three resting systolic BP (SBP) and diastolic BP (DBP) measurements were obtained using an automated cuff (Dynamap, Waukesha, WI) following 10 minutes (min) of seated rest and with 2-minute intervals between each measurement. The mean of these measurements was used. Body weight was measured and body mass index (BMI/kg/m<sup>2</sup>) was calculated. Resting heart rate (HR) was recorded. Subcutaneous fat was measured with skinfold calipers taken at the chest, abdomen, and thigh. Fasting blood samples were collected at rest prior to a 75&#x02009;g glucose load and at 120&#x02009;min postingestion to determine glucose handling. Glycosylated haemoglobin (HbA1c) was analyzed from resting blood samples. Glucose and HbA1c were analyzed commercially by a clinical laboratory (LAC, Lda., Maputo, Mozambique). VO<sub>2</sub> peak was evaluated from treadmill walking with metabolic measurements (MedGraphics, Minneapolis, MN) using a Balke walking protocol [<xref rid="B8" ref-type="bibr">8</xref>]. The test was terminated when subjects met three of the following five criteria: (i) a final rating of perceived exertion score of &#x02265;17 on the Borg scale (scale 6&#x02013;20), (ii) a respiratory exchange ratio &#x0003e;1.1, (iii) no change in HR with a change in workload, (iv) a &#x0201c;plateau&#x0201d; (increase of no &#x0003e;150&#x02009;mL) in oxygen uptake with an increase in workload, and (v) volitional fatigue, defined as an inability to keep up with the treadmill speed.</p></sec><sec id="sec2.3"><title>2.3. Intervention</title><p>These subjects were randomly allocated to either low intensity (LEX, <italic>n</italic> = 22), vigorous intensity (VEX, <italic>n</italic> = 9) exercise intervention, or to the control group (CON, <italic>n</italic> = 10) for 12 weeks. The LEX group underwent supervised exercises at 50% VO<sub>2</sub> peak for 45&#x02009;min/session, 3&#x02013;5 times/week, and the VEX group exercised under supervision at 75% VO<sub>2</sub> peak for 45&#x02009;min/session, 3 times/week.</p></sec><sec id="sec2.4"><title>2.4. Statistics</title><p>Statistical analyses were performed using the Statistical Package for Social Sciences (SPSS, version 16.0 for Windows). Baseline comparisons were made using independent <italic>t</italic>-tests. Since there were no differences for any outcome variables between the exercise groups, VEX and LEX data were combined into one exercise group (EX). Data were analyzed using a 2 &#x000d7; 2 (group (exercise versus controls) &#x000d7; pre/post-training) ANOVA with repeated measures. ANCOVA was used to compare postintervention BP while controlling for baseline BP variances. A Pearson <italic>r</italic> correlation was used to determine whether significant correlations existed between changes in HbA1c and SBP and HbA1c and DBP.</p></sec></sec><sec id="sec3"><title>3. Results</title><p>Subject characteristics and comparison between EX and CON at baseline and postintervention are shown in <xref ref-type="table" rid="tab2">Table 2</xref>. There were no differences in age, height, and baseline weight between the EX and CON groups. SBP and DBP at the end of the intervention were significantly lower in the EX than CON group after covarying for the baseline values (<italic>P</italic> &#x0003c; 0.05). HbA1c was significantly reduced in both groups combined, but there was no significant interaction effect. In response to the glucose load, the EX group had a significantly lower plasma glucose level than CON group (<italic>P</italic> &#x0003c; 0.05) following the exercise training (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Skinfold measurement revealed a reduction in subcutaneous chest and thigh fat in the EX group only after training. The change of HbA1c (&#x02212;1.0 &#x000b1; 0.3%) over the 12 weeks was significantly correlated with the change of SBP (0.3 &#x000b1; 2.7&#x02009;mm&#x02009;Hg, <italic>r</italic> = 0.4, <italic>P</italic> &#x0003c; 0.05) and DBP (&#x02212;1.4 &#x000b1; 1.5&#x02009;mm&#x02009;Hg, <italic>r</italic> = 0.4, <italic>P</italic> &#x0003c; 0.05) (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p></sec><sec id="sec4"><title>4. Discussion</title><p>Individuals with type 2 diabetes are encouraged to be physically active, yet it is not known whether adding exercise to physically active individuals with type 2 diabetes would improve glucose control. This study has demonstrated that adding a structured exercise intervention to already physically active East African males with type 2 diabetes improved glucose control over 12 weeks. In addition, improvement in resting BP and exercise capacity were also observed in the EX group and these improvements occurred without weight loss.</p><p>In the current study, the intensity and duration of the exercise training program met the recommendations made by public health guidelines for type 2 diabetes [<xref rid="B9" ref-type="bibr">9</xref>]. Despite unchanged VO<sub>2</sub> peak of EX over the 12&#x02009;wks, treadmill time during a VO<sub>2</sub> max test was increased after training, indicating improvement in work capacity. Considering that the participants already walked a minimum of 1&#x02009;hr per day, this finding indicates that addition of more intense exercise to already physically active individuals can improve work capacity, without significant changes in VO<sub>2</sub> max.</p><p>Lowering BP in diabetics is clinically beneficial. Hypertension, especially high SBP [<xref rid="B10" ref-type="bibr">10</xref>], is associated with diabetic nephropathy, retinopathy, neuropathy, and cardiovascular disease [<xref rid="B11" ref-type="bibr">11</xref>&#x02013;<xref rid="B13" ref-type="bibr">13</xref>]. In the UK Prospective Diabetes Study (UKPDS), significantly fewer diabetic micro- and macrovascular complications and diabetic-related deaths occurred in the group with a mean BP of 144/82&#x02009;mm&#x02009;Hg compared to the group with a mean BP of 154/87&#x02009;mm&#x02009;Hg [<xref rid="B14" ref-type="bibr">14</xref>]. The reduction in resting BP in the EX group observed in the present study was in accordance with previous findings, in which 12&#x02009;wks of aerobic training decreased BP in Africans with hypertension [<xref rid="B15" ref-type="bibr">15</xref>]. In our study, the exercise program reduced the mean SBP by 2&#x02009;mm&#x02009;Hg, whereas the mean SBP in CON group increased 7&#x02009;mm&#x02009;Hg. It has been estimated that a 2-mm&#x02009;Hg reduction of SBP results in a 6% reduction in stroke mortality and a 4% reduction in mortality attributable to coronary heart disease [<xref rid="B16" ref-type="bibr">16</xref>], thus, even the small reduction in BP observed in our study is clinically significant. Mean DBP was decreased in the EX group by 3&#x02009;mm&#x02009;Hg while increased in the CON group by 3&#x02009;mm&#x02009;Hg. Small decrements in DBP of 3&#x02009;mm&#x02009;Hg reduces the risk of stroke 25% and risk of coronary artery disease by 9% [<xref rid="B17" ref-type="bibr">17</xref>]. Although our BP findings may have been influenced by the baseline BP, the BP was not reduced and actually increased in the CON group. We further confirmed this finding by covarying for baseline SBP in the statistical analysis and finding significantly lower postintervention SBP in the EX group. Thus, it is unlikely our results can be explained by &#x0201c;regression towards to the mean&#x0201d;. The ~2&#x02009;mm&#x02009;Hg reduction in SBP and ~3&#x02009;mm&#x02009;Hg reduction in DBP are similar to the expected reduction from exercise training reported in a recent meta-analysis [<xref rid="B16" ref-type="bibr">16</xref>], suggesting that our EX group exhibited a standard reduction in BP in response to exercise training.</p><p>The decrease in HbA1c by 1.1% in EX is clinically significant, since a reduction in HbA1c by 0.6% was shown to reduce the risk of microvascular complications by 25% [<xref rid="B18" ref-type="bibr">18</xref>]. This finding is in agreement with Ronnemaa et al., who reported four months of physical exercise decreased HbA1c from 9.6 to 8.6% [<xref rid="B19" ref-type="bibr">19</xref>]. A recent review of the response of HbA1c levels to exercise training found a modest response (0.5&#x02013;1.0% reduction) or no response to training interventions [<xref rid="B20" ref-type="bibr">20</xref>]. The decrease in HbA1c by 0.7% in CON group is also clinically significant. The finding is in agreement with that of van Rooijen et al. [<xref rid="B21" ref-type="bibr">21</xref>], who reported reduced HbA1c in a relaxation group to the same extent as the exercise group in black female diabetics.</p><p>Exercise training had little impact on resting plasma glucose [<xref rid="B22" ref-type="bibr">22</xref>], but response to the glucose challenge was attenuated, while the CON group demonstrated no change, suggesting that additional exercise in physically active individuals can enhance glucose control. The disparity of improvements in the 2&#x02009;hr glucose level while there is no change in fasting glucose responses is in agreement with Krotkiewski et al. [<xref rid="B5" ref-type="bibr">5</xref>]. In their study, although fasting plasma glucose was unaltered, exercise training improved type 2 diabetic patients' performance during glucose tolerance tests. This evidence suggests that exercise training may provide a unique impact on postprandial glucose disposal, independent of weight loss or pharmacological agents used. Thus, our data show oral glucose tolerance was improved with a formal exercise training program in already active individuals with type 2 diabetes. Further research is needed to identify the mechanisms mediating the differential responses.</p><p>Both EX and CON exhibited small but significant increases in body mass and BMI compared to the baseline. The increase in body mass in the EX group implies that either the patients increased their daily energy intake or they diminished their habitual physical activity level outside the scheduled training, or their muscle mass was increased, or combined. Due to the difficulties of translating exercise history questionnaires into different lingual dialects, we failed to collect valid daily activity data outside the exercise intervention. However, local people use walking as their major means of transportation, and based on participant interviews, we are confident that they walked for at least 1 hour every day at baseline.</p><p>Physical activity may decrease total fat mass and visceral fat without weight loss in obese type 2 diabetics [<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B6" ref-type="bibr">6</xref>]. Excess fat, especially visceral fat, is closely associated with insulin resistance and the pathology of type 2 diabetes [<xref rid="B23" ref-type="bibr">23</xref>]. Although data from skinfold measurements indicated small changes in fat distributions in EX, waist circumference was unchanged. Thus, it is unlikely that abdominal fat changed in our study. It is also important to note that the diabetic population in the current study was much leaner than diabetics typically studied in western society. Based on average BMI of 27 and waist-hip ratio less than 1.0, the subjects in our study were not obese according to WHO standards. Although weight loss is a desirable strategy of treating diabetes in developed counties, in developing countries where physical activity is prevalent in their lifestyle, males with type 2 diabetes benefit from additional exercise training even without weight loss. This supports previous data demonstrating that exercise alone can improve glucose metabolism in type 2 diabetics [<xref rid="B6" ref-type="bibr">6</xref>]. Exercise training increases glucose disposal and decreases muscle insulin resistance through a number of mechanisms that may not necessarily be associated with weight loss. Insulin increases glucose transport in muscle by translocating GLUT 4 glucose transporting protein from intracellular stores to sarcolemma [<xref rid="B24" ref-type="bibr">24</xref>]. Training-induced changes by muscle contraction include increases in muscle GLUT 4 concentration, GLUT 4 mRNA [<xref rid="B7" ref-type="bibr">7</xref>], and glycogen synthase activity and changes in muscle composition, favoring increased glucose disposal [<xref rid="B25" ref-type="bibr">25</xref>]. A close correlation between glycogen synthase fractional activity and blood flow suggests that they are causally related in promoting glucose disposal [<xref rid="B26" ref-type="bibr">26</xref>]. Activation of the sympathetic nervous system and hypertension are associated with insulin resistance [<xref rid="B27" ref-type="bibr">27</xref>]. We have found a relationship between the changes of HbA1c and the changes in BP in our study. Because exercise training improves insulin sensitivity and glucose metabolism [<xref rid="B28" ref-type="bibr">28</xref>], this may be an important mechanism in mediating reductions in sympathetic outflow and BP. This would be consistent with previous data in hypertensive subjects demonstrating a close association between the reduction in resting BP and plasma norepinephrine and improved insulin sensitivity after exercise training [<xref rid="B29" ref-type="bibr">29</xref>]. This may at least partially explain the favorable BP and glucose metabolism changes we observed in our study.</p><p>
<italic>Limitations</italic>. Data on plasma insulin was not available because of a malfunction in the lab. We were also unable to collect reliable data on baseline and postprogram physical activity. Our findings may not apply to women, or to other populations in Africa with lifestyles different from those in Mozambique. Despite these limitations, the study provides insight on the effect of exercise training on individuals with type 2 diabetes in East Africa.</p></sec><sec id="sec5"><title>5. Conclusions</title><p>Adding exercise to already active African men with type 2 diabetes improved glucose control and BP without concomitant weight loss; thus additional exercise should be encouraged in those individuals who appear to have adequate physical activity levels. Exercise training can be viewed as beneficial on its own, independent of weight loss.</p></sec></body><back><sec sec-type="conflict"><title>Conflict of Interests</title><p>The authors declare that there is no conflict of interests regarding the publication of this paper.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>H</given-names></name><name><surname>Aubert</surname><given-names>RE</given-names></name><name><surname>Herman</surname><given-names>WH</given-names></name></person-group><article-title>Global burden of diabetes, 1995&#x02013;2025: prevalence, numerical estimates, and projections</article-title><source><italic>Diabetes Care</italic></source><year>1998</year><volume>21</volume><issue>9</issue><fpage>1414</fpage><lpage>1431</lpage><pub-id pub-id-type="other">2-s2.0-0031752685</pub-id><pub-id pub-id-type="pmid">9727886</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wild</surname><given-names>S</given-names></name><name><surname>Roglic</surname><given-names>G</given-names></name><name><surname>Green</surname><given-names>A</given-names></name><name><surname>Sicree</surname><given-names>R</given-names></name><name><surname>King</surname><given-names>H</given-names></name></person-group><article-title>Global prevalence of diabetes: estimates for the year 2000 and projections for 2030</article-title><source><italic>Diabetes Care</italic></source><year>2004</year><volume>27</volume><issue>5</issue><fpage>1047</fpage><lpage>1053</lpage><pub-id pub-id-type="other">2-s2.0-2342466734</pub-id><pub-id pub-id-type="pmid">15111519</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alemu</surname><given-names>T</given-names></name><name><surname>Lindtjom</surname><given-names>B</given-names></name></person-group><article-title>Physical activity, illness and nutritional status among adults in a rural Ethiopian community</article-title><source><italic>International Journal of Epidemiology</italic></source><year>1995</year><volume>24</volume><issue>5</issue><fpage>977</fpage><lpage>983</lpage><pub-id pub-id-type="other">2-s2.0-0028972952</pub-id><pub-id pub-id-type="pmid">8557456</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segal</surname><given-names>KR</given-names></name><name><surname>Edano</surname><given-names>A</given-names></name><name><surname>Abalos</surname><given-names>A</given-names></name><etal/></person-group><article-title>Effect of exercise training on insulin sensitivity and glucose metabolism in lean, obese, and diabetic men</article-title><source><italic>Journal of Applied Physiology</italic></source><year>1991</year><volume>71</volume><issue>6</issue><fpage>2402</fpage><lpage>2411</lpage><pub-id pub-id-type="other">2-s2.0-0026322241</pub-id><pub-id pub-id-type="pmid">1778939</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krotkiewski</surname><given-names>M</given-names></name><name><surname>Lonnroth</surname><given-names>P</given-names></name><name><surname>Mandroukas</surname><given-names>K</given-names></name></person-group><article-title>The effects of physical training on insulin secretion and effectiveness and on glucose metabolism in obesity and Type 2 (non-insulin-dependent) diabetes mellitus</article-title><source><italic>Diabetologia</italic></source><year>1985</year><volume>28</volume><issue>12</issue><fpage>881</fpage><lpage>890</lpage><pub-id pub-id-type="other">2-s2.0-0022354818</pub-id><pub-id pub-id-type="pmid">3912243</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kuk</surname><given-names>JL</given-names></name><name><surname>Davidson</surname><given-names>LE</given-names></name><etal/></person-group><article-title>Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without Type 2 diabetes</article-title><source><italic>Journal of Applied Physiology</italic></source><year>2005</year><volume>99</volume><issue>3</issue><fpage>1220</fpage><lpage>1225</lpage><pub-id pub-id-type="other">2-s2.0-24044524633</pub-id><pub-id pub-id-type="pmid">15860689</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dela</surname><given-names>F</given-names></name><name><surname>Ploug</surname><given-names>T</given-names></name><name><surname>Handberg</surname><given-names>A</given-names></name><etal/></person-group><article-title>Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM</article-title><source><italic>Diabetes</italic></source><year>1994</year><volume>43</volume><issue>7</issue><fpage>862</fpage><lpage>865</lpage><pub-id pub-id-type="other">2-s2.0-0028200755</pub-id><pub-id pub-id-type="pmid">8013748</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>DR</given-names></name><name><surname>Hosker</surname><given-names>JP</given-names></name><name><surname>Rudenski</surname><given-names>AS</given-names></name></person-group><article-title>Homeostasis model assessment: insulin resistance and <italic>&#x003b2;</italic>-cell function from fasting plasma glucose and insulin concentrations in man</article-title><source><italic>Diabetologia</italic></source><year>1985</year><volume>28</volume><issue>7</issue><fpage>412</fpage><lpage>419</lpage><pub-id pub-id-type="other">2-s2.0-0021813187</pub-id><pub-id pub-id-type="pmid">3899825</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albright</surname><given-names>A</given-names></name><name><surname>Franz</surname><given-names>M</given-names></name><name><surname>Hornsby</surname><given-names>G</given-names></name><etal/></person-group><article-title>ACSM position stand on exercise and Type 2 diabetes</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>2000</year><volume>32</volume><issue>7</issue><fpage>1345</fpage><lpage>1360</lpage><pub-id pub-id-type="other">2-s2.0-0034219151</pub-id><pub-id pub-id-type="pmid">10912903</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stratton</surname><given-names>IM</given-names></name><name><surname>Kohner</surname><given-names>EM</given-names></name><name><surname>Aldington</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis</article-title><source><italic>Diabetologia</italic></source><year>2001</year><volume>44</volume><issue>2</issue><fpage>156</fpage><lpage>163</lpage><pub-id pub-id-type="other">2-s2.0-0035134120</pub-id><pub-id pub-id-type="pmid">11270671</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehler</surname><given-names>PS</given-names></name><name><surname>Jeffers</surname><given-names>BW</given-names></name><name><surname>Estacio</surname><given-names>R</given-names></name><name><surname>Schrier</surname><given-names>RW</given-names></name></person-group><article-title>Associations of hypertension and complications in non-insulin-dependent diabetes mellitus</article-title><source><italic>American Journal of Hypertension</italic></source><year>1997</year><volume>10</volume><issue>2</issue><fpage>152</fpage><lpage>161</lpage><pub-id pub-id-type="other">2-s2.0-0031081469</pub-id><pub-id pub-id-type="pmid">9037322</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishihara</surname><given-names>M</given-names></name><name><surname>Yukimura</surname><given-names>Y</given-names></name><name><surname>Aizawa</surname><given-names>T</given-names></name></person-group><article-title>High blood pressure as risk factor in diabetic retinopathy development in NIDDM patients</article-title><source><italic>Diabetes Care</italic></source><year>1987</year><volume>10</volume><issue>1</issue><fpage>20</fpage><lpage>25</lpage><pub-id pub-id-type="other">2-s2.0-0023226148</pub-id><pub-id pub-id-type="pmid">3568963</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knowler</surname><given-names>WC</given-names></name><name><surname>Bennett</surname><given-names>PH</given-names></name><name><surname>Ballintine</surname><given-names>EJ</given-names></name></person-group><article-title>Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians</article-title><source><italic>The New England Journal of Medicine</italic></source><year>1980</year><volume>302</volume><issue>12</issue><fpage>645</fpage><lpage>650</lpage><pub-id pub-id-type="other">2-s2.0-0018864599</pub-id><pub-id pub-id-type="pmid">6986550</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><article-title>Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group</article-title><source><italic>British Medical Journal</italic></source><year>1998</year><volume>317</volume><issue>7160</issue><fpage>703</fpage><lpage>713</lpage><pub-id pub-id-type="pmid">9732337</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akinpelu</surname><given-names>AO</given-names></name></person-group><article-title>Responses of the African hypertensive to exercise training: preliminary observations</article-title><source><italic>Journal of Human Hypertension</italic></source><year>1990</year><volume>4</volume><issue>2</issue><fpage>74</fpage><lpage>76</lpage><pub-id pub-id-type="other">2-s2.0-0025236835</pub-id><pub-id pub-id-type="pmid">2338694</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornelissen</surname><given-names>VA</given-names></name><name><surname>Fagard</surname><given-names>RH</given-names></name></person-group><article-title>Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors</article-title><source><italic>Hypertension</italic></source><year>2005</year><volume>46</volume><issue>4</issue><fpage>667</fpage><lpage>675</lpage><pub-id pub-id-type="other">2-s2.0-31944451925</pub-id><pub-id pub-id-type="pmid">16157788</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pescatello</surname><given-names>LS</given-names></name><name><surname>Franklin</surname><given-names>BA</given-names></name><name><surname>Fagard</surname><given-names>R</given-names></name><name><surname>Farquhar</surname><given-names>WB</given-names></name><name><surname>Kelley</surname><given-names>GA</given-names></name><name><surname>Ray</surname><given-names>CA</given-names></name></person-group><article-title>American College of Sports Medicine position stand. Exercise and hypertension</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>2004</year><volume>36</volume><issue>3</issue><fpage>533</fpage><lpage>553</lpage><pub-id pub-id-type="other">2-s2.0-3242810652</pub-id><pub-id pub-id-type="pmid">15076798</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><article-title>Effect of intensive blood-glucose control with metformin on complications in overweight patients with Type 2 diabetes (UKPDS 34)</article-title><source><italic>The Lancet</italic></source><year>1998</year><volume>352</volume><issue>9131</issue><fpage>854</fpage><lpage>865</lpage><pub-id pub-id-type="other">2-s2.0-0032511566</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronnemaa</surname><given-names>T</given-names></name><name><surname>Mattila</surname><given-names>K</given-names></name><name><surname>Lehtonen</surname><given-names>A</given-names></name><name><surname>Kallio</surname><given-names>V</given-names></name></person-group><article-title>A controlled randomized study on the effect of long-term physical exercise on the metabolic control in Type 2 diabetic patients</article-title><source><italic>Acta Medica Scandinavica</italic></source><year>1986</year><volume>220</volume><issue>3</issue><fpage>219</fpage><lpage>224</lpage><pub-id pub-id-type="other">2-s2.0-0023033340</pub-id><pub-id pub-id-type="pmid">3535397</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boul&#x000e9;</surname><given-names>NG</given-names></name><name><surname>Haddad</surname><given-names>E</given-names></name><name><surname>Kenny</surname><given-names>GP</given-names></name><name><surname>Wells</surname><given-names>GA</given-names></name><name><surname>Sigal</surname><given-names>RJ</given-names></name></person-group><article-title>Effects of exercise on glycemic control and body mass in Type 2 diabetes mellitus: a meta-analysis of controlled clinical trials</article-title><source><italic>Journal of the American Medical Association</italic></source><year>2001</year><volume>286</volume><issue>10</issue><fpage>1218</fpage><lpage>1227</lpage><pub-id pub-id-type="other">2-s2.0-0035850403</pub-id><pub-id pub-id-type="pmid">11559268</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Rooijen</surname><given-names>AJ</given-names></name><name><surname>Rheeder</surname><given-names>P</given-names></name><name><surname>Eales</surname><given-names>CJ</given-names></name><name><surname>Becker</surname><given-names>PJ</given-names></name></person-group><article-title>Effect of exercise versus relaxation of haemoglobin A1C in black females with Type 2 diabetes mellitus</article-title><source><italic>Quarterly Journal of Medicine</italic></source><year>2004</year><volume>97</volume><issue>6</issue><fpage>343</fpage><lpage>351</lpage><pub-id pub-id-type="other">2-s2.0-3042694918</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelley</surname><given-names>DE</given-names></name><name><surname>Goodpaster</surname><given-names>BH</given-names></name></person-group><article-title>Effects of exercise on glucose homeostasis in Type 2 diabetes mellitus</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>2001</year><volume>33</volume><issue>6</issue><fpage>S495</fpage><lpage>S501</lpage><pub-id pub-id-type="other">2-s2.0-0034994741</pub-id><pub-id pub-id-type="pmid">11427776</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazaki</surname><given-names>Y</given-names></name><name><surname>DeFronzo</surname><given-names>RA</given-names></name></person-group><article-title>Visceral fat dominant distribution in male Type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type</article-title><source><italic>Cardiovascular Diabetology</italic></source><year>2009</year><volume>8</volume><issue>article 44</issue><pub-id pub-id-type="other">2-s2.0-69249189794</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dela</surname><given-names>F</given-names></name><name><surname>Handberg</surname><given-names>A</given-names></name><name><surname>Mikines</surname><given-names>KJ</given-names></name><name><surname>Vinten</surname><given-names>J</given-names></name><name><surname>Galbo</surname><given-names>H</given-names></name></person-group><article-title>GLUT 4 and insulin receptor binding and kinase activity in trained human muscle</article-title><source><italic>Journal of Physiology</italic></source><year>1993</year><volume>469</volume><fpage>615</fpage><lpage>624</lpage><pub-id pub-id-type="other">2-s2.0-0027328741</pub-id><pub-id pub-id-type="pmid">8271219</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>A</given-names></name><name><surname>Sj&#x000f6;din</surname><given-names>A</given-names></name><name><surname>Olsson</surname><given-names>R</given-names></name><name><surname>Vessby</surname><given-names>B</given-names></name></person-group><article-title>Effects of physical exercise on phospholipid fatty acid composition skeletal muscle</article-title><source><italic>American Journal of Physiology</italic></source><year>1998</year><volume>274</volume><issue>3</issue><fpage>E432</fpage><lpage>E438</lpage><pub-id pub-id-type="other">2-s2.0-0031978655</pub-id><pub-id pub-id-type="pmid">9530125</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebeling</surname><given-names>P</given-names></name><name><surname>Bourey</surname><given-names>R</given-names></name><name><surname>Koranyi</surname><given-names>L</given-names></name><etal/></person-group><article-title>Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activity</article-title><source><italic>Journal of Clinical Investigation</italic></source><year>1993</year><volume>92</volume><issue>4</issue><fpage>1623</fpage><lpage>1631</lpage><pub-id pub-id-type="other">2-s2.0-0027482270</pub-id><pub-id pub-id-type="pmid">8408617</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>EA</given-names></name><name><surname>Hoffman</surname><given-names>RP</given-names></name><name><surname>Balon</surname><given-names>TW</given-names></name><name><surname>Sinkey</surname><given-names>CA</given-names></name><name><surname>Mark</surname><given-names>AL</given-names></name></person-group><article-title>Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans</article-title><source><italic>Journal of Clinical Investigation</italic></source><year>1991</year><volume>87</volume><issue>6</issue><fpage>2246</fpage><lpage>2252</lpage><pub-id pub-id-type="other">2-s2.0-0025995364</pub-id><pub-id pub-id-type="pmid">2040704</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henriksen</surname><given-names>EJ</given-names></name></person-group><article-title>Invited review: effects of acute exercise and exercise training on insulin resistance</article-title><source><italic>Journal of Applied Physiology</italic></source><year>2002</year><volume>93</volume><issue>2</issue><fpage>788</fpage><lpage>796</lpage><pub-id pub-id-type="other">2-s2.0-0036021855</pub-id><pub-id pub-id-type="pmid">12133893</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohrt</surname><given-names>WM</given-names></name><name><surname>Malley</surname><given-names>MT</given-names></name><name><surname>Coggan</surname><given-names>AR</given-names></name><etal/></person-group><article-title>Effects of gender, age, and fitness level on response of VO<sub>2</sub>max to training in 60&#x02013;71&#x02009;yr olds</article-title><source><italic>Journal of Applied Physiology</italic></source><year>1991</year><volume>71</volume><issue>5</issue><fpage>2004</fpage><lpage>2011</lpage><pub-id pub-id-type="other">2-s2.0-0025935444</pub-id><pub-id pub-id-type="pmid">1761503</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Plasma glucose at 120&#x02009;min during oral glucose tolerance test at baseline and postintervention in EX and CON groups. *<italic>P</italic> &#x0003c; 0.05 interaction effect; <sup>&#x02021;</sup>
<italic>P</italic> &#x0003c; 0.05 between EX and CON.</p></caption><graphic xlink:href="ISRN.ENDOCRINOLOGY2014-864897.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Changes of HbA1c was significantly correlated with (a) changes of SBP (<italic>P</italic> &#x0003c; 0.05) and (b) changes of DBP (<italic>P</italic> &#x0003c; 0.05) after intervention.</p></caption><graphic xlink:href="ISRN.ENDOCRINOLOGY2014-864897.002"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>A summary of medications.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">&#x02009;</th><th align="center" rowspan="1" colspan="1">EX </th><th align="center" rowspan="1" colspan="1">CON</th><th align="center" rowspan="1" colspan="1">Classification</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Nifedipine</td><td align="center" rowspan="1" colspan="1">0 (0)</td><td align="center" rowspan="1" colspan="1">1 (10)</td><td align="center" rowspan="1" colspan="1">antihypertensive</td></tr><tr><td align="left" rowspan="1" colspan="1">Amiloride</td><td align="center" rowspan="1" colspan="1">8 (20)</td><td align="center" rowspan="1" colspan="1">3 (30)</td><td align="center" rowspan="1" colspan="1">antihypertensive</td></tr><tr><td align="left" rowspan="1" colspan="1">Hydrochlorothiazide</td><td align="center" rowspan="1" colspan="1">16 (39)</td><td align="center" rowspan="1" colspan="1">6 (60)</td><td align="center" rowspan="1" colspan="1">antihypertensive</td></tr><tr><td align="left" rowspan="1" colspan="1">Methyldopa</td><td align="center" rowspan="1" colspan="1">4 (10)</td><td align="center" rowspan="1" colspan="1">0 (0)</td><td align="center" rowspan="1" colspan="1">antihypertensive</td></tr><tr><td align="left" rowspan="1" colspan="1">Enalapril</td><td align="center" rowspan="1" colspan="1">12 (29)</td><td align="center" rowspan="1" colspan="1">1 (10)</td><td align="center" rowspan="1" colspan="1">antihypertensive</td></tr><tr><td align="left" rowspan="1" colspan="1">Chlorthalidone</td><td align="center" rowspan="1" colspan="1">3 (7)</td><td align="center" rowspan="1" colspan="1">0 (0)</td><td align="center" rowspan="1" colspan="1">antihypertensive</td></tr><tr><td align="left" rowspan="1" colspan="1">Metformin</td><td align="center" rowspan="1" colspan="1">13 (32)</td><td align="center" rowspan="1" colspan="1">3 (30)</td><td align="center" rowspan="1" colspan="1">antidiabetic</td></tr><tr><td align="left" rowspan="1" colspan="1">Glyburide</td><td align="center" rowspan="1" colspan="1">25 (61)</td><td align="center" rowspan="1" colspan="1">6 (60)</td><td align="center" rowspan="1" colspan="1">antidiabetic</td></tr><tr><td align="left" rowspan="1" colspan="1">Atenolol</td><td align="center" rowspan="1" colspan="1">1 (2)</td><td align="center" rowspan="1" colspan="1">1 (10)</td><td align="center" rowspan="1" colspan="1">antihypertensive</td></tr></tbody></table><table-wrap-foot><fn><p>Numbers are expressed as count (percentage within this group).</p></fn><fn><p>Many subjects were on multiple medications.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Comparison between EX and CON at baseline and after intervention.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">&#x02009;</th><th align="center" colspan="2" rowspan="1">EX</th><th align="center" colspan="2" rowspan="1">CON</th></tr><tr><th align="left" rowspan="1" colspan="1">&#x02009;</th><th align="center" rowspan="1" colspan="1">Baseline</th><th align="center" rowspan="1" colspan="1">Post</th><th align="center" rowspan="1" colspan="1">Baseline</th><th align="center" rowspan="1" colspan="1">Post</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">53 &#x000b1; 2</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">55 &#x000b1; 3</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Height</td><td align="center" rowspan="1" colspan="1">170.0 &#x000b1; 1.2</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">170.3 &#x000b1; 1.3</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg)<sup>#</sup>
</td><td align="center" rowspan="1" colspan="1">78.8 &#x000b1; 2.4</td><td align="center" rowspan="1" colspan="1">79.7 &#x000b1; 2.4</td><td align="center" rowspan="1" colspan="1">78.4 &#x000b1; 4.3</td><td align="center" rowspan="1" colspan="1">79.7 &#x000b1; 4.3</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI<sup>#</sup>
</td><td align="center" rowspan="1" colspan="1">27.2 &#x000b1; 0.7</td><td align="center" rowspan="1" colspan="1">27.4 &#x000b1; 0.7</td><td align="center" rowspan="1" colspan="1">27.0 &#x000b1; 1.3</td><td align="center" rowspan="1" colspan="1">27.5 &#x000b1; 1.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Waist circumference (cm)</td><td align="center" rowspan="1" colspan="1">95.8 &#x000b1; 2.2</td><td align="center" rowspan="1" colspan="1">94.2 &#x000b1; 1.9</td><td align="center" rowspan="1" colspan="1">95.1 &#x000b1; 3.7</td><td align="center" rowspan="1" colspan="1">95.0 &#x000b1; 2.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Hip circumference (cm)</td><td align="center" rowspan="1" colspan="1">99.7 &#x000b1; 1.5</td><td align="center" rowspan="1" colspan="1">98.7 &#x000b1; 1.5</td><td align="center" rowspan="1" colspan="1">98.9 &#x000b1; 2.6</td><td align="center" rowspan="1" colspan="1">98.2 &#x000b1; 2.6</td></tr><tr><td align="left" rowspan="1" colspan="1">SBP (mmHg) </td><td align="center" rowspan="1" colspan="1">131 &#x000b1; 3<sup>&#x02021;</sup>
</td><td align="center" rowspan="1" colspan="1">129 &#x000b1; 4<sup>&#x000a7;</sup>
</td><td align="center" rowspan="1" colspan="1">145 &#x000b1; 6</td><td align="center" rowspan="1" colspan="1">152 &#x000b1; 6</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP (mmHg) </td><td align="center" rowspan="1" colspan="1">80 &#x000b1; 1<sup>&#x02021;</sup>
</td><td align="center" rowspan="1" colspan="1">77 &#x000b1; 2<sup>&#x000a7;</sup>
</td><td align="center" rowspan="1" colspan="1">80 &#x000b1; 3</td><td align="center" rowspan="1" colspan="1">83 &#x000b1; 3</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma glucose (mmol/L)</td><td align="center" rowspan="1" colspan="1">10.3 &#x000b1; 0.9</td><td align="center" rowspan="1" colspan="1">9.6 &#x000b1; 0.7</td><td align="center" rowspan="1" colspan="1">9.0 &#x000b1; 1.5</td><td align="center" rowspan="1" colspan="1">11.1 &#x000b1; 1.3</td></tr><tr><td align="left" rowspan="1" colspan="1">HbA1c (%)<sup>#</sup>
</td><td align="center" rowspan="1" colspan="1">8.8 &#x000b1; 0.5</td><td align="center" rowspan="1" colspan="1">7.7 &#x000b1; 0.4</td><td align="center" rowspan="1" colspan="1">8.4 &#x000b1; 0.9</td><td align="center" rowspan="1" colspan="1">7.7 &#x000b1; 0.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Time on treadmill (min)*</td><td align="center" rowspan="1" colspan="1">10.7 &#x000b1; 0.7</td><td align="center" rowspan="1" colspan="1">12.4 &#x000b1; 0.8<sup>&#x02020;</sup>
</td><td align="center" rowspan="1" colspan="1">9.8 &#x000b1; 1.7</td><td align="center" rowspan="1" colspan="1">9.6 &#x000b1; 1.8</td></tr><tr><td align="left" rowspan="1" colspan="1">
VO<sub>2</sub> max (mL/kg/min) </td><td align="center" rowspan="1" colspan="1">23.1 &#x000b1; 1.0</td><td align="center" rowspan="1" colspan="1">25.0 &#x000b1; 1.3</td><td align="center" rowspan="1" colspan="1">21.6 &#x000b1; 2.5</td><td align="center" rowspan="1" colspan="1">22.5 &#x000b1; 3.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Chest skinfold (cm)<sup>#</sup>
</td><td align="center" rowspan="1" colspan="1">19.3 &#x000b1; 1.4</td><td align="center" rowspan="1" colspan="1">14.8 &#x000b1; 1.0<sup>&#x02020;</sup>
</td><td align="center" rowspan="1" colspan="1">21.8 &#x000b1; 3.0</td><td align="center" rowspan="1" colspan="1">16.2 &#x000b1; 2.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Abdominal skinfold (cm)</td><td align="center" rowspan="1" colspan="1">22.7 &#x000b1; 1.2</td><td align="center" rowspan="1" colspan="1">22.8 &#x000b1; 1.5</td><td align="center" rowspan="1" colspan="1">21.3 &#x000b1; 2.6</td><td align="center" rowspan="1" colspan="1">23.0 &#x000b1; 3.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Thigh skinfold (cm)*</td><td align="center" rowspan="1" colspan="1">16.3 &#x000b1; 1.3</td><td align="center" rowspan="1" colspan="1">14.1 &#x000b1; 1.5<sup>&#x02020;</sup>
</td><td align="center" rowspan="1" colspan="1">15.8 &#x000b1; 2.7</td><td align="center" rowspan="1" colspan="1">16.2 &#x000b1; 3.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Total skinfold (cm)<sup>#</sup>
</td><td align="center" rowspan="1" colspan="1">59.0 &#x000b1; 3.2</td><td align="center" rowspan="1" colspan="1">52.4 &#x000b1; 3.4<sup>&#x02020;</sup>
</td><td align="center" rowspan="1" colspan="1">58.9 &#x000b1; 3.4</td><td align="center" rowspan="1" colspan="1">55.4 &#x000b1; 7.0</td></tr></tbody></table><table-wrap-foot><fn><p>Note: values are mean &#x000b1; SEM; </p></fn><fn><p>VO<sub>2</sub> max: maximal aerobic capacity; </p></fn><fn><p>BMI: body mass index;</p></fn><fn><p>*<italic>P</italic> &#x0003c; 0.05 interaction effect; <sup>#</sup>
<italic>P</italic> &#x0003c; 0.05 time effect; <sup>&#x000a7;</sup>
<italic>P</italic> &#x0003c; 0.05 between EX and CON after covarying for baseline; <sup>&#x02021;</sup>
<italic>P</italic> &#x0003c; 0.05 between EX and CON; <sup>&#x02020;</sup>
<italic>P</italic> &#x0003c; 0.05 between baseline and post in EX.</p></fn></table-wrap-foot></table-wrap></floats-group></article>